Wordt geladen...
Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease
Long-acting muscarinic antagonists (LAMAs), along with long-acting β(2)-agonists (LABAs), are the mainstay for treatment of patients with COPD. Glycopyrrolate, or glycopyrronium bromide, like other LAMAs, inhibits parasympathetic nerve impulses by selectively blocking the binding of acetylcholine to...
Bewaard in:
| Gepubliceerd in: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6003532/ https://ncbi.nlm.nih.gov/pubmed/29928118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S162646 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|